Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | Addressing Pushback to Our COVID Vaccine Efficacy Prediction

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    20 January 2021
    Published byCGS-CIMB

    Our neutralizing antibody (NAb) vs. vaccine efficacy (VE) correlation analysis (see here) stimulated some good discussion. Here we expand on common pushbacks. In particular, our initial analysis did not adjust for disease severity in convalescent controls, which would introduce false precision in o